RGNX REGENXBIO Inc.

Fundamentals / CIK 0001590877 / USD

REGENXBIO Inc. reported $153.9M in revenue and a net loss of $175.2M for the trailing twelve months ended September 30, 2026 (down 69.2% year over year), with a -95.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RGNX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$493.2M$246.6M$0-$302.1MFY 2016 Revenue: $4.59MFY 2016 Net Income: -$62.97M2016FY 2017 Revenue: $10.39MFY 2017 Net Income: -$73.17M2017FY 2018 Revenue: $218.5MFY 2018 Net Income: $99.94M2018FY 2019 Revenue: $35.23MFY 2019 Net Income: -$94.73M2019FY 2020 Revenue: $154.6MFY 2020 Net Income: -$111.2M2020FY 2021 Revenue: $470.3MFY 2021 Net Income: $127.8M2021FY 2022 Revenue: $112.7MFY 2022 Net Income: -$280.3M2022FY 2023 Revenue: $90.24MFY 2023 Net Income: -$263.5M2023FY 2024 Revenue: $83.33MFY 2024 Net Income: -$227.1M2024FY 2025 Revenue: $170.4MFY 2025 Net Income: -$193.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $170.4M $83.33M $90.24M $112.7M $470.3M $154.6M $35.23M $218.5M $10.39M $4.59M
Cost of Revenue -- $33.57M $37.21M $54.55M $51.83M $35.71M $8.24M $9.64M $1.71M $98K
Gross Profit -- $49.76M $53.03M $58.18M $418.5M $118.9M $26.99M $208.9M $8.68M $4.49M
Research & Development $228.3M $208.5M $232.3M $242.5M $181.4M $166.3M $124.2M $83.87M $57.22M $45.48M
Operating Income -$161.2M -$233.3M -$268.1M -$262.9M $160.0M -$119.2M -$149.0M $88.10M -$75.89M -$65.34M
EBITDA -$145.6M -$217.1M -$250.8M -$250.0M $169.5M -$110.8M -$141.8M $92.08M -$73.20M -$64.80M
Interest Income $12.20M $12.10M $9.10M $5.50M -- -- -- -- -- --
Interest Expense $45.01M $12.66M $6.86M $23.25M $26.28M $771K -- -- -- --
Income Before Tax -$193.9M -$227.1M -$263.6M -$280.4M $141.2M -$106.0M -$97.49M $104.1M -$73.17M -$63.40M
Income Tax Expense $0 $0 -$152K -$84K $13.41M $5.24M -$2.75M $4.18M $0 -$435K
Net Income -$193.9M -$227.1M -$263.5M -$280.3M $127.8M -$111.2M -$94.73M $99.94M -$73.17M -$62.97M
Basic EPS -$3.76 -$4.59 -$6.02 -$6.50 $3.01 -$2.98 -$2.58 $2.99 -$2.45 -$2.38
Diluted EPS -$3.76 -$4.59 -$6.02 -$6.50 $2.91 -$2.98 -$2.58 $2.73 -$2.45 -$2.38
Basic Shares Outstanding 51.6M 49.5M 43.7M 43.2M 42.4M 37.3M 36.7M 33.4M 29.9M 26.4M
Diluted Shares Outstanding 51.6M 49.5M 43.7M 43.2M 43.9M 37.3M 36.7M 36.6M 29.9M 26.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $9.16M $108.0M $6.39M $30.34M $29.73M $21.36M $89.01M $21.21M
Cost of Revenue -- -- -- -- -- -- -- $6.32M
Gross Profit -- -- -- -- -- -- -- $14.90M
Research & Development $61.01M $56.09M $57.34M $59.61M $56.10M $59.50M $53.09M $50.38M
Operating Income -$35.53M $29.26M -$83.36M -$57.64M -$52.41M -$63.28M $12.13M -$51.37M
EBITDA -$32.02M $33.02M -$79.50M -$53.77M -$48.52M -$59.37M $16.08M -$47.34M
Interest Income $2.30M $1.20M $2.00M $2.80M $3.60M $3.40M $2.50M $2.90M
Interest Expense $7.47M $7.79M $8.71M $12.28M $13.17M $10.99M $8.57M $9.42M
Net Income -$40.74M $22.71M -$90.05M -$67.15M -$61.94M -$70.87M $6.08M -$51.19M
Basic EPS -$0.62 $0.43 -$1.72 -- -$1.20 -$1.38 $0.12 --
Diluted EPS -$0.62 $0.43 -$1.72 -- -$1.20 -$1.38 $0.12 --
Basic Shares Outstanding 65.3M 52.8M 52.4M -- 51.7M 51.5M 51.4M --
Diluted Shares Outstanding 65.3M 53.0M 52.4M -- 51.7M 51.5M 51.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $34.47M $57.53M $34.52M $96.95M $345.2M $338.4M $69.51M $75.56M $46.66M $24.84M
Short-Term Investments $195.6M $177.2M $240.7M $267.7M $112.2M $137.3M $226.7M $244.2M $114.1M $64.71M
Cash & Short-Term Investments $240.9M $244.9M $314.1M $565.2M $849.3M $522.5M $400.0M $470.6M $176.4M $159.0M
Accounts Receivable, Net $26.38M $20.47M $24.79M $28.08M $32.44M $43.00M $38.15M $31.60M $5.85M --
Other Current Assets $12.90M $13.77M $20.40M $9.35M $10.20M $1.95M $4.20M $3.83M $1.41M $1.01M
Total Current Assets $281.3M $278.0M $335.0M $416.0M $518.8M $531.2M $345.0M $337.9M $168.0M $93.37M
Property, Plant & Equipment, Net $104.9M $117.6M $132.1M $141.7M $131.5M $56.47M $28.97M $28.70M $13.98M $9.32M
Long-Term Investments $10.79M $10.18M $38.87M $200.6M $391.9M $46.81M $103.8M $150.8M $15.62M $69.41M
Other Non-Current Assets $4.61M $4.00M $4.81M $6.40M $6.43M $5.28M $4.55M $2.31M $862K $400K
Total Non-Current Assets $171.8M $188.0M $239.0M $417.3M $595.1M $177.0M $152.9M $205.9M $30.68M $79.36M
Total Assets $453.0M $466.0M $574.0M $833.3M $1.11B $708.2M $497.9M $543.8M $198.7M $172.7M
Accounts Payable $21.36M $22.80M $22.79M $27.21M $11.39M $10.62M $6.41M $4.41M $4.83M $1.54M
Deferred Revenue (Current) $10.45M $115K $148K $1.83M $3.33M $449K -- $600K -- --
Total Current Liabilities $118.1M $103.2M $130.3M $130.4M $130.5M $81.45M $33.68M $22.18M $14.44M $9.67M
Deferred Revenue (Non-Current) $18.94M -- -- -- -- $3.78M $3.33M $3.33M -- --
Other Non-Current Liabilities $638K $3.63M $6.25M $8.83M $745K $524K $1.83M $2.50M -- --
Total Non-Current Liabilities $232.2M $103.1M $132.0M $186.6M $219.1M $249.0M $14.04M $12.79M $1.21M $1.33M
Total Liabilities $350.3M $206.3M $262.2M $317.1M $349.6M $330.4M $47.71M $34.97M $15.65M $10.99M
Total Debt (incl. Leases) $73.50M $82.03M $89.29M $94.80M $86.68M $72.65M $11.29M $5.85M -- --
Common Stock $5.0K $5.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $3.0K $3.0K
Retained Earnings -$1.13B -$932.1M -$705.0M -$441.6M -$161.2M -$289.1M -$177.8M -$83.02M -$187.8M -$114.6M
Accumulated Other Comp. Income -$687K -$741K -$4.43M -$15.40M -$2.57M -$360K $205K -$720K -$715K -$33K
Total Stockholders' Equity $102.7M $259.7M $311.7M $516.2M $764.3M $377.8M $450.2M $508.8M $183.0M $161.7M
Total Equity $102.7M $259.7M $311.7M $516.2M $764.3M $377.8M $450.2M $508.8M $183.0M $161.7M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $95.80M $36.49M $15.23M $34.47M $58.80M $79.56M $130.1M $57.53M
Short-Term Investments $155.2M $69.03M $135.3M $195.6M $215.4M $243.7M $137.8M $177.2M
Cash & Short-Term Investments $251.0M $105.5M $150.5M $240.9M $302.0M $363.6M $272.7M $244.9M
Accounts Receivable, Net $8.54M $106.8M $10.04M $26.38M $25.35M $20.20M $18.19M $20.47M
Other Current Assets $48.15M $11.76M $14.44M $12.90M $19.47M $19.48M $16.08M $13.77M
Total Current Assets $320.9M $236.2M $186.5M $281.3M $332.0M $373.8M $313.2M $278.0M
Property, Plant & Equipment, Net $95.35M $98.45M $101.9M $104.9M $107.5M $111.0M $114.5M $117.6M
Long-Term Investments -- -- -- $10.79M $27.84M $40.30M $4.86M $10.18M
Other Non-Current Assets $5.30M $5.90M $5.51M $4.61M $4.27M $1.88M $2.99M $4.00M
Total Non-Current Assets $145.1M $150.5M $155.4M $171.8M $193.2M $207.3M $177.7M $188.0M
Total Assets $466.0M $386.6M $341.9M $453.0M $525.2M $581.0M $490.9M $466.0M
Accounts Payable $13.48M $15.55M $21.21M $21.36M $22.27M $21.66M $19.04M $22.80M
Deferred Revenue (Current) $5.99M $9.88M $5.92M $10.45M $13.20M $13.98M $13.59M $115K
Total Current Liabilities $67.68M $82.62M $71.11M $118.1M $124.6M $119.5M $106.7M $103.2M
Deferred Revenue (Non-Current) $16.22M $15.40M $22.78M $18.94M $21.19M $23.80M $26.30M --
Other Non-Current Liabilities $475K $486K $622K $638K $648K $664K $680K $3.63M
Total Non-Current Liabilities $250.3M $232.2M $249.7M $232.2M $239.2M $247.8M $110.0M $103.1M
Total Liabilities $318.0M $314.9M $320.8M $350.3M $363.8M $367.3M $216.7M $206.3M
Total Debt (incl. Leases) $66.55M $68.95M $71.07M $73.50M $76.51M $77.70M $79.85M $82.03M
Common Stock $7.0K $5.0K $5.0K $5.0K $5.0K $5.0K $5.0K $5.0K
Retained Earnings -$1.23B -$1.19B -$1.22B -$1.13B -$1.06B -$996.9M -$926.1M -$932.1M
Accumulated Other Comp. Income -$1.04M -$875K -$870K -$687K -$652K -$750K -$762K -$741K
Total Stockholders' Equity $148.0M $71.77M $21.08M $102.7M $161.5M $213.7M $274.2M $259.7M
Total Equity $148.0M $71.77M $21.08M $102.7M $161.5M $213.7M $274.2M $259.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$193.9M -$227.1M -$263.5M -$280.3M $127.8M -$111.2M -$94.73M $99.94M -$73.17M -$62.97M
Depreciation & Amortization $15.62M $16.21M $17.32M $12.91M $9.56M $8.41M $7.15M $3.98M $2.69M $544K
Stock-Based Compensation $34.56M $38.46M $40.27M $40.79M $38.81M $31.95M $26.85M $16.64M $10.61M $7.03M
Change in Receivables -$7.66M $9.71M $3.94M $4.82M $14.12M -$9.90M -$8.62M -$16.80M $561K $1.07M
Change in Payables -$2.28M -$292K -$2.79M $18.79M -$2.30M $3.87M $1.53M -$218K $2.62M $186K
Operating Cash Flow -$124.0M -$173.1M -$218.4M -$207.5M $218.9M -$54.06M -$107.7M $104.6M -$57.99M -$48.56M
Capital Expenditure -$2.41M -$2.44M -$9.96M -$30.72M -$84.17M -$26.87M -$11.72M -$13.28M -$7.16M -$8.15M
Free Cash Flow -$126.4M -$175.6M -$228.4M -$238.2M $134.7M -$80.93M -$119.4M $91.37M -$65.15M -$56.71M
Purchases of Investments -$332.6M -$190.1M -$86.56M -$184.9M -$498.1M -$123.0M -$190.7M -$445.8M -$68.63M -$45.07M
Investing Cash Flow -$15.87M $103.4M $190.9M -$11.93M -$406.6M $122.8M $93.56M -$279.4M -$4.79M $19.39M
Common Stock Issued -- -- -- -- -- -- -- $189.7M $81.99M --
Financing Cash Flow $116.8M $92.68M -$34.97M -$28.84M $195.2M $200.2M $8.38M $204.4M $84.60M $119K
Net Change in Cash -$23.06M $23.00M -$62.43M -$248.3M $7.48M $268.9M -$5.77M $29.73M $21.82M -$29.05M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$40.74M $22.71M -$90.05M -$67.15M -$61.94M -$70.87M $6.08M -$51.19M
Depreciation & Amortization $3.52M $3.76M $3.86M $3.87M $3.89M $3.90M $3.96M $4.02M
Stock-Based Compensation $8.12M $9.05M $8.62M $8.38M $9.00M $8.65M $8.54M $9.54M
Change in Receivables $98.22M -$96.71M $18.25M -$561K -$6.31M -$2.36M $1.57M $8.13M
Change in Payables -$2.05M -$5.29M $349K -$1.86M $694K $2.53M -$3.65M $3.04M
Operating Cash Flow $38.61M -$62.24M -$76.19M -$52.29M -$55.96M -$49.34M $33.63M -$31.62M
Capital Expenditure -$194K -$760K -$1.24M -$508K -$491K -$391K -$1.02M -$1.08M
Free Cash Flow $38.41M -$63.00M -$77.42M -$52.80M -$56.45M -$49.73M $32.60M -$32.70M
Purchases of Investments -$128.9M $0 -$9.84M -$62.81M -$39.52M -$211.1M -$19.16M -$16.22M
Investing Cash Flow -$86.15M $65.92M $70.59M $37.54M $42.29M -$140.4M $44.74M $40.27M
Financing Cash Flow $106.9M $17.57M -$13.64M -$9.58M -$7.08M $139.2M -$5.79M -$7.74M
Net Change in Cash $59.31M $21.26M -$19.24M -$24.34M -$20.76M -$50.55M $72.58M $909K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- 59.7% 58.8% 51.6% 89.0% 76.9% 76.6% 95.6% 83.6% 97.9%
Operating Margin -94.6% -280.0% -297.1% -233.2% 34.0% -77.1% -422.9% 40.3% -730.2% -1423.8%
Net Profit Margin -113.8% -272.5% -292.0% -248.7% 27.2% -72.0% -268.9% 45.7% -704.0% -1372.1%
Return on Equity (ROE) -188.7% -87.5% -84.5% -54.3% 16.7% -29.5% -21.0% 19.6% -40.0% -38.9%
Return on Assets (ROA) -42.8% -48.7% -45.9% -33.6% 11.5% -15.7% -19.0% 18.4% -36.8% -36.5%
Current Ratio 2.38x 2.69x 2.57x 3.19x 3.98x 6.52x 10.25x 15.24x 11.64x 9.66x
Quick Ratio 2.26x 2.57x 2.60x 4.55x 6.76x 6.94x 13.01x 22.65x 12.62x 16.44x
Debt to Equity 0.72x 0.32x 0.29x 0.18x 0.11x 0.19x 0.03x 0.01x -- --
Revenue Growth (YoY) +104.5% -7.7% -19.9% -76.0% +204.3% +338.7% -83.9% +2002.4% +126.5% -39.5%
Gross Profit Growth (YoY) -- -6.2% -8.9% -86.1% +252.1% +340.3% -87.1% +2305.2% +93.4% -40.0%
Operating Income Growth (YoY) -- -- -- -264.3% -- -- -269.1% -- -- --
Net Income Growth (YoY) -- -- -- -319.3% -- -- -194.8% -- -- --
EPS Growth (YoY) -- -- -- -315.9% -- -- -186.3% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -194.8% -- -- -202.9% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -276.8% -- -- -230.7% -- -- --
5Y Revenue / Share Growth -20.3% +75.3% -68.4% +651.0% +6278.2% +401.2% -58.5% +149.1% -- --
10Y Revenue / Share Growth +299.5% -27.3% -21.4% -- -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -301.5% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- -- -- -- -- 59.7%
Operating Margin -95.7% -94.1% -292.3% -94.6% -96.0% -105.7% -100.4% -280.0%
Net Profit Margin -113.9% -112.6% -330.2% -113.8% -110.3% -112.7% -100.6% -272.5%
Return on Equity (ROE) -118.4% -273.7% -1375.6% -188.7% -110.2% -82.2% -57.5% -87.5%
Return on Assets (ROA) -37.6% -50.8% -84.8% -42.8% -33.9% -30.2% -32.1% -48.7%
Current Ratio 4.74x 2.86x 2.62x 2.38x 2.66x 3.13x 2.93x 2.69x
Quick Ratio 3.83x 2.57x 2.26x 2.26x 2.63x 3.21x 2.73x 2.57x
Debt to Equity 0.45x 0.96x 3.37x 0.72x 0.47x 0.36x 0.29x 0.32x
Revenue Growth (YoY) -69.2% +405.7% -92.8% +43.0% +22.9% -4.2% +469.8% -4.5%
Gross Profit Growth (YoY) -- -- -- -- -- -- -- +35.7%
Operating Income Growth (YoY) -- -- -787.4% -- -- -- -- --
Net Income Growth (YoY) -- -- -1580.4% -- -- -- -- --
EPS Growth (YoY) -- -- -1533.3% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -326.5% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -- -337.5% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001590877) · from December 31, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:36 UTC · Open in terminal